Richard Marx: HazardiTunesAmazon

Richard Marx: HazardiTunesAmazon

£6.5m investment in Yorkshire cancer treatments

£6.5m investment in Yorkshire cancer treatments

Published at 7:04am 24th March 2016. (Updated at 6:12pm 24th March 2016)

Yorkshire Cancer Research has revealed plans to invest £6.5 million in new initiatives which will improve lung cancer outcomes and increase early diagnosis.

The investment follows expert workshops held in January to help determine the charity’s funding priorities for this year.

They were attended by more than 100 influential and experienced leaders in early diagnosis. 

The charity is inviting applications for funding in six key areas:

  • New ways to help people understand cancer signs and symptoms and seek help in deprived communities.
  • Using GP surgeries to increase participation in the national screening programmes for bowel, cervical and breast cancer.
  • Testing new tools which will help GPs spot cancer earlier.
  • Trialling innovative devices, radiotherapy, surgery and chemotherapy in lung cancer or new technology and approaches in early diagnosis.
  • Identifying people at risk of lung cancer using CT scans.
  • Raising standards of treatment for lung cancer in Yorkshire’s hospitals to match the very best.

Lung cancer is the most common cancer in Yorkshire, with around 4,500 people diagnosed with the disease every year.

15 of 21 Clinical Commissioning Groups in Yorkshire had incidence rates higher than the national average in 2013.

This differs from the national picture, where lung cancer is the third most common behind breast cancer and prostate cancer.

Around 67% of lung cancer patients are diagnosed at a late stage in Yorkshire, when the tumour may have grown or spread to other tissues or organs.

The investment will mark the first stage of the charity’s new strategy to ensure that 2,000 more people in the region survive cancer every year by 2025.

Successful projects will be announced in January 2017.

Charles Rowett, Chief Executive of Yorkshire Cancer Research, said: "We are delighted to be able to announce yet another significant investment in improving the diagnosis, treatment and care of people living in our region. This is only possible thanks to the continued support of people living in Yorkshire.

"Together, we can start having a real impact on cancer outcomes by finding practical solutions to our region's problems and by working in the heart of our communities."

More information about Yorkshire Cancer Research at www.ycr.org.uk